DMK PHARMACEUTICALS CORPORATION: capex
| Value | {"amount": 481006, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-09-30 |
| Status | current |
| Entity | DMK PHARMACEUTICALS CORPORATION |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cdfad7f0-706d-476d-a1b5-b6cb3dfe3f35
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001387131-21-011405 · Open the official SEC filing →Retrieved: 2026-08-19T08:54:25.189173+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000887247/capex/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cdfad7f0-706d-476d-a1b5-b6cb3dfe3f35
History
- supersedes {"amount": 714697, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001387131-20-009722)